| __timestamp | Exelixis, Inc. | Mesoblast Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 25111000 | 25980000 |
| Thursday, January 1, 2015 | 37172000 | 23748000 |
| Friday, January 1, 2016 | 191454000 | 42548000 |
| Sunday, January 1, 2017 | 452477000 | 2412000 |
| Monday, January 1, 2018 | 853826000 | 17341000 |
| Tuesday, January 1, 2019 | 967775000 | 16722000 |
| Wednesday, January 1, 2020 | 987538000 | 32156000 |
| Friday, January 1, 2021 | 1434970000 | 7456000 |
| Saturday, January 1, 2022 | 1611062000 | 10211000 |
| Sunday, January 1, 2023 | 1830208000 | 7501000 |
| Monday, January 1, 2024 | 2168701000 | 5902000 |
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Exelixis, Inc. has demonstrated remarkable growth, with its revenue increasing by over 7,000% from 2014 to 2023. This surge is a testament to its strategic advancements and market positioning. In contrast, Mesoblast Limited has experienced a more modest revenue trajectory, with fluctuations and a peak in 2016. By 2023, Exelixis's revenue was approximately 250 times that of Mesoblast, highlighting a significant divergence in their financial performances. The data also reveals a gap in 2024 for Exelixis, suggesting potential reporting delays or strategic shifts. As the biotech industry continues to evolve, these insights provide a glimpse into the competitive landscape and the factors driving success.
Vertex Pharmaceuticals Incorporated or Exelixis, Inc.: Who Leads in Yearly Revenue?
Vertex Pharmaceuticals Incorporated or Mesoblast Limited: Who Leads in Yearly Revenue?
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.: Examining Key Revenue Metrics
Alnylam Pharmaceuticals, Inc. and Mesoblast Limited: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs Mesoblast Limited
Revenue Insights: Biogen Inc. and Exelixis, Inc. Performance Compared
Exelixis, Inc. and Ionis Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Exelixis, Inc. or Arrowhead Pharmaceuticals, Inc.?
Revenue Insights: Exelixis, Inc. and ImmunityBio, Inc. Performance Compared
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Lantheus Holdings, Inc. vs Mesoblast Limited: Annual Revenue Growth Compared